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Abstract
Background: To assess the quality of life (QoL) and predictors thereof in Dutch adult hereditary
and non-hereditary retinoblastoma (RB) survivors.
Methods: In this population-based cross-sectional study, a generic QoL questionnaire (SF-36) and
a disease-specific interview were administered to 87 adult RB survivors aged 18 to 35 years. Their
QoL data were compared with those of a Dutch healthy reference group. Among the RB
hereditary/non-hereditary survivors, the QoL was compared and predictors for QoL were
identified by linear multiple regression analyses.
Results: As a group, RB survivors scored significantly lower than the reference group on the SF-
36 subscale 'mental health' (t = -27, df = 86, p < 0.01). Hereditary RB survivors scored lower on
the subscale 'general health' (t = 2.6, df = 85, p < 0.01) than non-hereditary RB survivors. Having
experienced bullying, as a child was a predictor for the SF-36 subscales: 'physical functioning' (p <
0.05), 'role functioning physical' (p < 0.01), 'role functioning emotional' (p < 0.05) and 'social
functioning' (p < 0.01). Having experienced bullying (p < 0.01), but also subjective experience of
impairment related to RB (p < 0.05), was predictors for 'general health'. Subjective experience of
impairment was a predictor for 'vitality' (p < 0.01) and 'bodily pain' (p < 0.01).
Conclusion: In this exploratory study, it appears that the group of adult RB survivors experience
a relatively good overall but slightly decreased QoL compared with the reference group. However,
they report more problems with regard to their mental health (anxiety, feelings of depression, and
loss of control). Hereditary RB survivors differ significantly from non-hereditary RB survivors only
in 'general health'. Bullying in childhood and subjective experience of impairment are the main
predictors of a worse QoL. In order to prevent worsening of QoL, or perhaps to improve it,
clinicians should make an inventory of these issues at an early stage. We recommend further
research to assess the specific psychological factors that may lead to mental health problems in this
population.
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Background
Retinoblastoma (RB) is the most common malignant
intraocular tumor in childhood. In the Netherlands, the
incidence is 1:17,000 newborns (approximately 10–15
new patients every year) [1]. RB is generally classified into
a hereditary and a non-hereditary form. The hereditary
cases (40%) are caused by a germline mutation and both
eyes are usually affected. In most cases (60%), the disease
is non-hereditary and affects only one eye. However, it is
estimated that approximately 10% of patients with unilat-
eral RB still have a germline mutation [2]. The aim of the
treatment of RB is to cure the disease and preserve vision
[3]. In the western world RB has an excellent 5-year sur-
vival rate of more than 90% [4]. However, the late effects
of RB (such as risk of offspring with hereditary RB, enucle-
ation of the eye, cosmetic deformities as a result of treat-
ment [5], enhanced risk for second primary tumors in
hereditary patients [6,7] and visual impairment [8,9])
may affect many aspects of a person's life.
Measures of quality of life (QoL) enable to assess a
patient's perception of the impact of their disease on their
social, mental and physical state. As the vast majority
(90%) of children survive RB, knowledge about their QoL
is important. Although many studies have explored the
effect of an ocular tumor on QoL in adults, to date only
one study has assessed the long-term consequences of RB.
Byrne et al. (1995) [10] concluded that self-perception of
health, types of employment and life achievements did
not differ between adult survivors and controls, but survi-
vors were less likely to marry and more likely to divorce;
in addition, absence of pregnancies was more common
among married survivors than among controls. In child-
hood the QoL of RB survivors appears to be diminished,
but later consequences into adulthood are not yet clear
[11-13].
A study on uveal melanoma patients indicated that radio-
therapy caused reduced QoL because of vision loss, pain,
uncertainty about the disease, fear of recurrent tumor and
death by metastatic disease [14]. However, because uveal
melanoma develops later in life and has a poorer survival
rate (< 50%), this condition may not be entirely compara-
ble to the consequences experienced by adult RB patients.
Studies have indicated that childhood cancer survivors
experience a diminished QoL in adulthood [15-17]. It is
unclear, however, whether the same applies to RB survi-
vors. Clinicians involved in adult RB care in the Nether-
lands observe an extensive and far-reaching burden of that
condition, even though the disease originates from early
childhood. However, there are no studies on the QoL of
adult RB survivors to confirm this impression, and we
have found no study that elucidates the relationship
between treatment for RB and long-term functioning and
wellbeing.
To address this issue, we assessed QoL in Dutch adult RB
survivors (aged 18–35 years) with the aim to identify pre-
dictors for a decreased QoL. A comparison was made with
QoL norm data from an age-matched population of
Dutch healthy persons and a comparison was made
between hereditary RB survivors and non-hereditary RB
survivors. We hypothesize that hereditary RB survivors
have poorer QoL than non-hereditary RB survivors, con-
sidering the fact that hereditary RB survivors mostly have
bilateral RB, enhanced risk of second primary tumors and
risk of offspring with RB. The results of this study provide
insight into the QoL of hereditary and non-hereditary RB
patients that may contribute to the development of more
specific psychosocial patient care.
Methods
The present study has a cross-sectional design. From June
2005 to June 2006 all eligible RB survivors known in the
national Dutch RB register [18] were invited to participate
in this study. The national Dutch RB register is unique
because it has maintained virtually complete data from
1945 until 2006. Eligibility requirements for inclusion in
this study were: (1) age between 18–35 years, (2) suffi-
cient command of the Dutch language to understand the
questionnaire and the interview; (3) adequate cognitive
abilities for the same reason, and (4) treatment for RB in
the VU University Medical Center (Amsterdam), the Uni-
versity Medical Center Utrecht, or the University Medical
Center St. Radboud (Nijmegen); these three hospitals
have had treatment responsibility for 86% of the national
patient population.
Survivors of RB were sent a letter with an invitation to par-
ticipate. Informed written consent was obtained from all
respondents. Participants who had agreed to participate
were contacted by telephone, information was given, and
appointments were made to visit the survivors at home for
personal communication and a semi-structured interview.
One week before the home visit, participants received the
SF-36 self-report questionnaire to be filled out. This study
was approved by the Ethics Committees, and was con-
ducted in accordance with the principles of the Helsinki
declaration.
Measures
Hospital charts
Predictors of QoL that were obtained from hospital charts
were: age at diagnosis, date of birth, gender (male/
female), hereditary status (non-hereditary/hereditary),
laterality (unilateral/bilateral), type of treatment, and vis-
ual acuity. Treatment was categorized as: 1) only enuclea-
tion, 2) only external beam radiotherapy, 3) combination
of enucleation and radiotherapy, and 4) a combination of
enucleation and remaining therapies (chemothermother-
apy, plaque radiotherapy, laser photocoagulation and cry-
otherapy) [2]. Visual acuity was defined as the visual
acuity after subjective refraction in the participant's betterHealth and Quality of Life Outcomes 2007, 5:30 http://www.hqlo.com/content/5/1/30
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eye and categorized according to the WHO guidelines [19]
as: 1) normal vision (> 0.3), 2) low vision (0.05–0.3), and
3) blindness (< 0.05). If hospital charts were not available
the information was obtained by personal communica-
tion.
Semi-structured interview
Prior to the home visits, the semi-structured interview was
developed. Topics for the interview were obtained from
literature, clinical observations and from focus group dis-
cussions [20] with eight experts and six RB survivors.
Extensive semi-structured interviews were conducted
(JvD) with the RB survivors focusing on early adaptation
to the diagnosis, and perceived burden of their illness in
relation to educational achievement and social function-
ing. For the present study, we only report data from the
semi-structured interviews that are appropriate for quanti-
fication. Educational level was categorized as: 1) lower
(primary or secondary school), 2) middle (high school or
professional education), and 3) higher (college and uni-
versity). Content analysis was used to extract data on per-
ceived impairment related to RB (yes/no), and on the
experience of being bullied because of RB (yes/no). Fur-
thermore, data on marital status (single/living together)
and life events were extracted. The life events were inven-
toried by asking whether any of the following life events
had occurred: accidents, other disease besides RB, disease
of a member of the family, death of a family member or
death of a best friend, divorce, divorce of parents, moving,
sexual abuse, enprisonment, enprisonment of parent, loss
of job, admission into a psychiatric hospital, admission of
a parent into a psychiatric hospital. Answers were catego-
rized into: 1) no life events occurred, 2) one or two life
events occurred, 3) more than two life events occurred.
Quality of life measures
The dependent variable, QoL, was measured by the Dutch
version of the Medical Outcome Study Short-Form 36 (SF-
36) [21]. The SF-36 is a widely used and well-validated
generic QoL instrument. Recently, the SF-36 was recom-
mended when used in studies in long-term survivors of
childhood cancer [22]. The SF-36 contains eight separate
subscales representing physical, psychological, and social
functioning. It measures four dimensions of physical
health: 'physical functioning' (ability to perform physical
activities without limitations), 'role functioning physical'
(possibility to work or perform daily role functions with-
out interference from physical health problems), 'bodily
pain' (pain interfering with daily activities) and 'general
health perception' (self-evaluation of overall health sta-
tus) and four dimensions of mental health: 'vitality'
(energy), 'social functioning' (impact of physical or emo-
tional problems on normal social activities), 'role func-
tioning emotional' (capacity to perform daily activities
without interference from emotional problems) and
'mental health' (anxiety, feelings of depression and loss of
control). Per domain, raw scores were transformed to
standardized scores on a scale from 0 to 100, with a higher
score reflecting a better QoL. In order to compare the QoL
of RB survivors with the general Dutch population, SF-36
scores available from age-matched controls of the general
Dutch population were used [23]. The proportion females
in the age-matched general Dutch population is 53% and
is not statistically significant (Chi-Square Test, p = 0.26)
from the proportion females among the RB survivors
(61%). Internal consistency reliability (Cronbach's alpha)
for the different areas of physical and mental health range
from 0.78 ('general health') to 0.92 ('physical function-
ing') [23].
Statistical analysis
Analyses were carried out using the software package SPSS
11.5 for Windows. Differences in socio-demographic and
psychosocial characteristics between hereditary and non-
hereditary RB survivors were examined with Student's t-
tests. Differences in frequencies were examined with Chi-
Square tests. One sample t-tests were used to test differ-
ences in SF-36 subscales between the RB group and the
reference group. Independent sample t-tests were used to
compare mean scores of hereditary RB survivors with non-
hereditary RB survivors, because we expect that hereditary
RB survivors have poorer QoL than non-hereditary RB sur-
vivors. Possible predictors of the QoL subscales were stud-
ied by linear multiple regression. Stepwise, univariate
general linear model analysis was used to determine the
best predictive model of each SF-36 subscale score
(dependent variables). Variables that were likely to affect
the SF-36 subscales were included in the regression model
as a fixed set of variables. These (independent) variables
were: gender, life events, socio-economic status, age at
interview, age at diagnosis, type of treatment, heredity, lat-
erality, visual acuity, subjective experience of impairment,
and experience of being bullied in childhood. Variables
that were likely to affect the QoL subscales with a signifi-
cant effect (p < 0.05) were included in the final model and
reported. In all tests, p-values of less than 0.05 were
deemed to be statistically significant.
Results
Of the 148 adult survivors that were eligible for our study,
21 (14%) survivors could not be traced and were therefore
not approached for participation. Of the remaining 127
survivors, 95 (75%) survivors agreed to cooperate and 87
(69%) of them completed the study, including the SF-36
questionnaire and a semi-structured interview. Of the
non-participating 32 survivors (25%): 20 (16%) preferred
not to participate, 10 (8%) did not respond within the
study period, and 2 (2%) had moved abroad. Reasons for
not taking part were mainly lack of time, no interest in the
study or not wanting to be confronted again with their
disease. Comparison of age, hereditary status, and treat-
ment revealed no significant differences between the par-
ticipating RB survivors and the non-participants.Health and Quality of Life Outcomes 2007, 5:30 http://www.hqlo.com/content/5/1/30
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However, more women (61%) than men were willing to
participate in the study.
Table 1 presents data on socio-demographic and psycho-
social characteristics of the study participants, and differ-
ences between hereditary and non-hereditary subgroups
of RB survivors.
Quality of life (SF-36)
Table 2 shows standardized scores derived from the SF-36
with the comparison between the RB group and the Dutch
reference group. Survivors of RB scored lower on the sub-
scale mental health (mean difference = 18.1, p < 0.001)
compared with the norm data from an age-matched
Dutch healthy reference group [23]. All other SF-36 sub-
scales showed no significant differences between the RB
group and the reference group.
Table 2 shows standardized scores derived from the SF-36
with the comparison between hereditary RB survivors vs
non-hereditary RB survivors. Hereditary RB survivors
scored lower on the subscale general health (mean differ-
ence = 8.6, p = 0.01) compared with the non-hereditary
RB survivors. All other SF-36 subscales showed no signifi-
cant differences between the hereditary RB survivors and
non-hereditary RB survivors.
Predictors of quality of life
The results of the multiple regression analyses can be
found in Table 3. Eleven variables were included as inde-
Table 1: Socio-demographic and psychosocial characteristics
All RB survivors 
(N = 87)
Hereditary RB survivors
(N = 36)
Non-hereditary RB survivors
(N = 51)
Age at interview Years: mean (SD) 26.4 (5.3) 26.8 (4.8) 26.2 (5.7)
Age at diagnosis Years: mean (SD) 2 (2.0) 0.69 (1.6)* 2.7 (1.8)*
Gender (N (%))
Female 53 (61%) 25 (69%) 23 (45%)
Education (N (%))
Low 16 (18%) 8 (22%) 8 (16%)
Middle 33 (38%) 14 (39%) 19 (37%)
High 38 (44%) 14 (39%) 24 (47%)
Marital status (N (%))
Single 37 (43%) 15 (42%) 21 (41%)
Laterality (N (%))
Unilateral rb 56 (64%) 5 (14%)* 51 (100%)*
Treatment (N (%))
Only enucleation 48 (55%) 5 (14%)* 43 (84%)*
Only radiotherapy 14 (16%) 14 (39%)*
Combi enucleation + radiotherapy 21 (24%) 14 (39%)* 7 (14%)*
Combi enucleation + chemo/laser 4 (5%) 3 (8%)* 1 (2%)*
Visual acuity (N (%))
Normal vision 78 (90%) 27 (75%)* 51 (100%)*
Low vision 6 (7%) 6 (17%)*
Blindness 3 (3%) 3 (8%)*
Life events (N (%))
None 20 (23%) 8 (22%) 12 (24%)
One or two 42 (36%) 17(47%) 25 (49%)
More than 2 22 (25%) 9 (25%) 13 (26%)
Missing 3 (3%) 2 (6%) 1 (2%)
Being bullied (N (%))
Yes 77 (88%) 34 (94%) 43 (84%)
Perceived impairment (N(%))
Yes 48 (55%) 20 (56%) 28 (55%)
*Significant difference (p < 0.05) between hereditary and non-hereditary survivors of RB.Health and Quality of Life Outcomes 2007, 5:30 http://www.hqlo.com/content/5/1/30
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pendent predictors in a linear multiple regression model.
Having experienced bullying was an independent predic-
tor of: physical functioning (p = 0.04), role functioning
physical (p = 0.002), role functioning emotional (p =
0.049) and social functioning (p = 0.011). Having experi-
enced bullying (R2 = 0.067, p = 0.023) and perceived
impairment (R2 = 0.059, p = 0.033) were both predictors
of general health. Perceived impairment was a predictor of
vitality (p < 0.001) and bodily pain (p = 0.039). Age, gen-
der, marital status, educational level, life events, heredity,
type of treatment, visual acuity and laterality did not pre-
dict any of the QoL aspects of the SF-36.
Discussion
The present study assessed the QoL of a unique Dutch
population of RB survivors using the SF-36 questionnaire
and a semi-structured interview focusing on early adapta-
tion to the diagnosis and the perceived burden of their ill-
ness in relation to educational achievement and social
functioning. To our knowledge, this is the first study to
examine long-term QoL in adult RB survivors.
Our results show no significant differences between the
adult RB survivors compared to the healthy reference
group in the QoL measures, except for the mental health
scale. RB survivors learn to live with many of the conse-
quences of their disease, but reported more problems with
regard to their mental health compared with the reference
group. This result is clinically significant, because the
mean MH score in the RB group was 18.1 points (3 stand-
ard deviations (SD), p < 0.001) lower than that of the
Dutch reference group. A difference of 18.1 points on a
scale from 0–100, means almost 20% difference between
the RB survivors and the Dutch reference group on the
MH scale. In particular, anxiety, feelings of depression and
loss of control seem to have a negative impact on their
lives. These unfavorable mood states might be caused by
their feelings of being different from others. According to
our survivor's reactions during the interview, this often
originates from having been bullied about their facial
appearance or prosthesis, and/or their visual impairment
or blindness. Besides that, loss of control may lead to feel-
ings of depression. In particular, realization about their
loss of control appears to be connected to the emotion of
shame [24], and experiencing shame in childhood can be
a forerunner of depression [25]. In the present study, our
group of RB survivors are more anxious and worried com-
pared with the reference group. They grew up with uncer-
tainty about their facial appearance and the feeling of
being different; this can lead to feelings of shame, which
may influence their perception and experiences during
general development and may eventually result in depres-
sion. This finding is consistent with results from other dis-
eases with atypical visible facial characteristics, such as
Table 2: Comparison of standardized SF-36 scores (SD) between RB group and Dutch reference group, and between non-hereditary 
RB survivors and hereditary RB survivors
SF-36 Domains Dutch reference group
(N = 701)
RB group
(N = 87)
Hereditary RB survivors
(N = 36)
Non-hereditary RB survivors
(N = 51)
Physical functioning 93.1 (11.8) 93.2 (12.9) 91.9 (15.9) 94.5 (9.9)
Role functioning physical 86.4 (27.6) 85.3 (29.7) 78.5 (32.8) 90.0 (26.7)
Bodily pain 80.9 (19.4) 84.5 (20.5) 82.9 (20.6) 85.3 (20.6)
General health 78.2 (17.3) 78.6 (20.4) 72.0 (21.6) * 83.4 (18.5) *
Vitality 70.7 (16.4) 71.5 (17.1) 72.2 (18.2) 70.9 (16.5)
Social functioning 87.8 (19.1) 89.2 (18.0) 88.5 (16.5) 89.5 (19.3)
Role functioning emotional 85.4 (30.0) 88.1 (28.3) 88.9 (27.6) 87.3 (29.3)
Mental health 78.7 (15.2) * 60.6 (6.3) * 62.1 (7.1) 59.5 (5.6)
* Significant difference between groups (p < 0.01)
Table 3: Multiple regression analyses (method stepwise)
Dependent variable F p R2 Independent variable β (standardized)
Physical functioning 4.258 0.042 0.049 Bullying -0.222
Role-physical functioning 9.812 0.002 0.107 Bullying -0.327
Role-emotional functioning 4.000 0.049 0.047 Bullying -0.216
Social functioning 6.703 0.011 0.076 Bullying -0.275
General health 4.998 0.003 0.167 Bullying
Impairment
-0.293
-0.233
Vitality 14.364 0.000 0.156 Impairment -0.394
Bodily Pain 4.431 0.039 0.054 Impairment -0.232Health and Quality of Life Outcomes 2007, 5:30 http://www.hqlo.com/content/5/1/30
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strabismus and patients with a cleft. Strabismus patients
experience more social anxiety [26], and have more diffi-
culties with self-image and interpersonal relationships
[27] in comparison with the reference group. Persons with
visible facial characteristics (like a cleft), expressed greater
dissatisfaction with their appearance [28]. Further
research should be conducted to identify the specific psy-
chological factors that lead to problems in mental health
in this population.
The second aim of this study was to compare the QoL of
hereditary RB survivors with that of non-hereditary RB
survivors. The general health perception of hereditary RB
survivors was significantly impaired compared with non-
hereditary RB survivors. This probably reflects a realistic
view of their situation. Hereditary RB survivors often expe-
rience more physical problems than the non-hereditary
group: i.e. they are often subjected to more treatments
[12], are bilaterally affected, have a greater chance of vis-
ual impairment, and are at greater risk of developing sec-
ond primary tumors. It is remarkable, however, that
despite these additional problems they do not report to be
affected in other QoL areas.
Another striking result is that non-hereditary RB survivors
also experience anxiety concerning second primary
tumors, even though they are at less risk for this compared
with hereditary RB survivors. Nowadays, clinicians can
estimate the probability of survivors passing on the dis-
ease to their offspring or the probability of developing sec-
ond primary tumors. However, for patients with a rare
disease, the impact of hearing that there is a 'low probabil-
ity' of something occurring might be received differently
from how clinicians may expect. From a healthy person's
perspective, a low probability generally means a minor or
no chance of having/passing on a certain disease. For a
person with a rare disease, however, a low probability
might logically mean the same but their own reality of
having a rare disease may have proven otherwise. The dis-
crepancy between theory and their own reality might
introduce fear (or at least some existential thoughts)
about why they could not escape from developing a rare
disease. This might explain the fears also experienced by
non-hereditary RB survivors. Therefore, clinicians should
be aware that RB survivors (including non-hereditary RB)
might interpret these probabilities differently from what
may be expected. A similar tendency was also found
among women at risk for breast cancer [29].
The third aim of the study was to gain insight into the pre-
dictors of QoL. Bullying in childhood and impairment
appeared to be the major predictors of QoL of our RB sur-
vivors. According to the interview results, the reasons for
bullying were in most cases related to the appearance of
the eye or to the survivor's facial appearance. This was also
found in another study on children with RB in which par-
ents reported that their child had experienced bullying
related to either facial appearance or the ocular prosthesis
[11]. The association between bullying and QoL has also
been reported in other types of childhood cancer [30].
Most of the impairments mentioned by survivors were
associated with a wide range of activities related to their
visual acuity. Lamoureux et al. (2004) [31] concluded that
the areas of greatest restriction in people with impaired
vision were associated with reading, outdoor mobility,
participation in leisure activities and shopping. It is
understandable that a serious restriction in these activities
is negatively related to the experience of health and vital-
ity.
This study focused on the QoL of a diverse and rare pop-
ulation of RB survivors and provides information on a
population-based RB group. Nevertheless, a number of
study limitations should be considered when interpreting
the results. First, since the possibilities of treatment have
improved over time, our results may no longer apply to
survivors who have been treated more recently. On the
other hand, some form of treatment will always be neces-
sary and the current RB treatments still do not leave the
appearance of the RB survivor totally unaffected; further
research is therefore desirable.
Second, it is conceivable that some of the RB survivors
who did not participate in the present study experienced a
poorer QoL than those who did participate. Indeed, sev-
eral non-participants refused participation because they
did not want to be confronted with their disease again; if
this subgroup consists of those who do not accept their
disease as well as the other subgroups, then the overall
QoL of RB survivors might be worse than reported here.
Third, we are aware of the fact that some SF-36 subscales
show ceiling effects [22]. Therefore, it can be that the
effects we found were underestimated. Estimates of the
coefficients and their standard errors are robust to the
non-normal distributions. Although the tests confidence
intervals originate from normal distributions the conse-
quences of violating this assumption are minor with suf-
ficient sample size.
Conclusion
In conclusion, our exploratory study indicates that adult
RB survivors generally experience a relatively good QoL
compared with the reference group. However, RB survi-
vors in our study have more problems with regard to their
mental health; particularly anxiety, feelings of depression
and loss of control influence their lives negatively. These
unfavorable mood states may be caused by their feelings
of being different from others and by childhood bullying.Health and Quality of Life Outcomes 2007, 5:30 http://www.hqlo.com/content/5/1/30
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Hereditary RB survivors differ from non-hereditary RB sur-
vivors, probably justifiably, only in their experience of
general health. In patients with RB, decreased QoL may
arise from the psychological effects of having been bullied
and from the negative experience of their impairments
related to the disease. In order to prevent worsening of
QoL, clinicians should not hesitate to address these issues
at an early stage. We recommend further research to assess
the specific psychological factors that may lead to mental
health problems in this population.
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